4
Changes in Ownership
Coherus Oncology, Inc. Filed Acc 0000899243-16-019192
Chief Technical Officer sold 21,493 shares at an average $26.89 ($578,038)
- Chief Technical Officer acquired 21,493 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Watler Peter K. · Chief Technical Officer
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2015-11-20 | Exercise or conversion : show line 1 in the form | +20,000 | $1.42 | $28,340 | 20,000 | I |
| 2015-11-20 | Sale : show line 2 in the form | −20,000 | $27.41 | $548,178 | 0 | I |
| 2016-05-02 | Exercise or conversion : show line 3 in the form | +1,493 | $2.08 | $3,111 | 1,493 | I |
| 2016-05-02 | Sale : show line 4 in the form | −1,493 | $20.00 | $29,860 | 0 | I |
| Open-market sales · 21,493 sh · avg $26.89 · $578,038 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2015-11-20 | Exercise or conversion : show line 5 in the form Stock Option (right to buy) | −20,000 | 39,988 | I |
| 2016-05-02 | Exercise or conversion : show line 6 in the form Stock Option (right to buy) | −1,493 | 55,495 | I |
Loading xslF345X03/doc4.xml…